Drug Trial Radar · NCT07558733
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
Apr 22, 2026
Primary completion
May 2029
Study completion May 2033
Sponsor
- Lead sponsor
- Faeth TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 30, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a Phase 1b/2, multi-center, open-label, dose escalation trial evaluating the safety and preliminary efficacy of sapanisertib and serabelisib (PIKTOR) with fulvestrant and/or other anticancer therapies in participants with HR+/HER2- advanced/metastatic breast cancer.
Conditions
- HR+ HER2- Breast Cancer
Interventions
SerabelisibDrug
Serabelisib is a selective, small molecule inhibitor of PI3Kα.
SapanisertibDrug
Sapanisertib is a small molecule inhibitor of the mammalian mTOR serine/threonine kinase.
FulvestrantDrug
Fulvestrant is a first-in-class SERD.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability of drugs by assessment of adverse events (AEs) / serious adverse events (SAEs)Time frame: 2 years
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
START Los Angeles
Los Angeles, California · Recruiting
Hoag Memorial Hospital Presbyterian
Newport Beach, California · Recruiting
Rocky Mountain Cancer Centers
Lone Tree, Colorado · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
Oncology Associates of Oregon
Springfield, Oregon · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Texas Oncology - Central/South
Austin, Texas · Recruiting
START San Antonio
San Antonio, Texas · Recruiting
Texas Oncology - San Antonio
San Antonio, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.